Source: New Indian Express
Context
The National Medical Commission (NMC) — through an advisory issued on 1 July 2026 by NMC Secretary Dr Raghav Langer — has directed all medical colleges and healthcare institutions in India to promote the Indian Council of Medical Research (ICMR)’s ‘Medical Innovations Patent Mitra’ platform among faculty, clinicians, researchers, and students. Launched by ICMR under the guidance of NITI Aayog, in partnership with the Department of Pharmaceuticals (DoP) and supported by DPIIT, the platform is a centralized, expert-driven digital IP incubator for India’s healthcare sector — offering end-to-end handholding assistance for patent filing, prior-art search, prosecution, maintenance, and technology transfer of biomedical innovations. Crucially, it provides 100% government-funded legal + financial support, eliminating out-of-pocket costs for innovators. Eligible participants include ICMR intramural + extramural researchers, faculty + clinicians + students at all recognised medical colleges, DPIIT-registered biomedical startups, and independent institute-led innovators. Union Health Minister JP Nadda launched the initiative at the International Symposium on Health Technology Assessment (ISHTA), and ICMR DG Dr Rajiv Bahl has said it aims to enable a tenfold rise in life-science patents filed in India in the next two years.
The NMC advisory at a glance
- Issued by: National Medical Commission (NMC).
- Signed by: Dr Raghav Langer — Secretary, NMC.
- Directed to: All medical colleges + healthcare institutions in India.
- Purpose: Widely disseminate information about ICMR’s Medical Innovations Patent Mitra initiative among faculty, clinicians, researchers, and students.
- Message: “Active participation by medical colleges and institutions will play an important role in strengthening India’s healthcare innovation ecosystem.”
What is the Medical Innovations Patent Mitra initiative?
- A centralized, expert-driven digital platform for India’s healthcare sector.
- Type: Institutional Intellectual Property (IP) incubator.
- Launched by: Indian Council of Medical Research (ICMR).
- Guided by: NITI Aayog.
- Partner: Department of Pharmaceuticals (DoP) — under Ministry of Chemicals and Fertilizers.
- Supporter: Department for Promotion of Industry and Internal Trade (DPIIT) — under Ministry of Commerce and Industry.
- Launched at: International Symposium on Health Technology Assessment (ISHTA) — by Union Health Minister JP Nadda.
- Portal: patentmitra.icmr.org.in.
- Purpose: Handholding support to protect, manage, maintain, and commercialize biomedical breakthroughs.
What are the aims of the initiative?
- Eliminate financial + bureaucratic hurdles that prevent Indian researchers from filing domestic and international patents.
- Move high-value medical research out of laboratory notebooks into scalable healthcare devices, diagnostics, and therapeutics.
- Bridge the gap between science and industry.
- Strengthen India’s biomedical innovation ecosystem.
- Advance Ayushman Bharat + Viksit Bharat + Atmanirbhar Bharat goals.
What are the key services offered?
- 100% Government-Funded Legal Assistance:
- Covers patent filing costs.
- Legal drafting fees.
- Application prosecution charges.
- Lifecycle maintenance fees.
- Zero out-of-pocket cost for selected innovators.
- Expert Prior-Art Assessment:
- Access to specialised IP attorneys + medical experts.
- Rigorous prior-art searches to confirm patentability.
- High-quality patent drafting to avoid international rejections.
- End-to-End Patent Prosecution:
- Answering examination reports.
- Handling patent opposition hearings.
- Strategic management of IP portfolios.
- Streamlined Technology Transfer Framework:
- Connects academic innovators with commercial pharma + medical device manufacturers.
- Uses Med Tech “Mela” mechanism.
- Uses paperless Expression of Interest (EoI) process.
- Enables smooth licensing agreements + technology transfer to industry.
What is ICMR?
- Full form: Indian Council of Medical Research.
- Established: 1911 (as Indian Research Fund Association – IRFA); renamed ICMR in 1949.
- Headquarters: New Delhi.
- Parent: Department of Health Research (DHR), Ministry of Health & Family Welfare.
- Role: India’s apex body for the formulation, coordination, and promotion of biomedical research.
- Director General (2026): Dr Rajiv Bahl — also Secretary, DHR (since October 2023).
- Institutes: ~30 permanent research institutes/centres across India (including NIV Pune, NARI Pune, NIRRCH Mumbai, RMRC Bhubaneswar).
- Related initiative: MedTech Mitra — launched 2023 to support medical device innovation.
Related initiatives in health innovation
- MedTech Mitra (2023) — ICMR’s parallel initiative for medical devices.
- India Innovation Fund.
- BIRAC (Biotechnology Industry Research Assistance Council) — under DBT; supports biotech startups.
- Startup India (2016) — DPIIT programme; ~1,60,000+ registered startups.
- Ayushman Bharat Digital Mission (ABDM) — digital health infrastructure.
- National Digital Health Mission.
Practice MCQs
Q1. With reference to the Medical Innovations Patent Mitra initiative, consider the following statements:
- It has been launched by the Indian Council of Medical Research (ICMR).
- It was launched under the guidance of NITI Aayog and in partnership with the Department of Pharmaceuticals (DoP).
- It provides fully government-funded support for patent filing and technology transfer.
- It is available only to ICMR’s internal research institutes and not to external innovators.
How many of the above statements are correct?
(a) Only one (b) Only two (c) Only three (d) All four (e) None
(Statement 4 is wrong; the initiative is NOT restricted to ICMR’s internal research institutes — it also covers ICMR extramural grantees, faculty + clinicians + students of medical colleges, DPIIT-registered biomedical startups, and independent institute-led innovators across India.)
Q2. With reference to the National Medical Commission (NMC), consider the following statements:
- It was established on 25 September 2020, replacing the erstwhile Medical Council of India (MCI).
- It is governed by the National Medical Commission Act, 2019.
- It functions under the Ministry of Health and Family Welfare.
- Its four autonomous boards include UGMEB, PGMEB, MARB, and EMRB.
How many of the above statements are correct?
(a) Only one (b) Only two (c) Only three (d) All four (e) None
(All four statements are correct.)
Answer Key
- (c) — Statement 4 wrong: Not restricted to ICMR internal institutes.
- (d) — All correct.
Exam Relevance
- UPSC Prelims & Mains: CRITICAL — GS-II (Governance, Government Schemes, Health, IPR); GS-III (S&T, Innovation, IPR); Prelims (ICMR, NMC, DPIIT, IP schemes); Mains-Essay on Innovation Ecosystem.
- NABARD Grade A: Medium — General awareness on innovation policy.
- State PCS: Medium-High — Especially relevant for states with strong medical education systems.
- RBI Grade B (Phase I + II): Medium-High — ESI on innovation ecosystem, IPR, financial support for startups.
